CSL Ltd
OTC:CSLLY
CSL Ltd
OTC:CSLLY
Price:
25.49
USD
0.87%
Market Cap:
$24.7B
Relative Value
The Relative Value of one
CSLLY
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 25.49 USD,
CSL Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CSLLY Relative Value
HIDDEN
Multiples Across Competitors
CSLLY Competitors Multiples
CSL Ltd Competitors
CSL Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
CSL Ltd
OTC:CSLLY
|
70.8B USD | 3.3 | 35.9 | 11.8 | 14.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
405.8B USD | 6.7 | 97.9 | 16 | 22.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.2B USD | 5.4 | 25.6 | 14.7 | 14.7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178.1B USD | 6.1 | 21.1 | 13.2 | 16.3 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
117.9B USD | 9.8 | 29.6 | 22.3 | 23.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.6 | 18 | 13.4 | 15.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 10.9 | 35.1 | 38.1 | 38.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.9B USD | 11.5 | 136.5 | 76.1 | 84.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
